XML 112 R95.htm IDEA: XBRL DOCUMENT v3.10.0.1
Equity Method and Other Investments - Term Loan Receivable, Convertible Debt, and Warrant (Details) - USD ($)
$ in Millions
12 Months Ended
Nov. 28, 2016
Sep. 30, 2016
Sep. 30, 2015
BioCision, LLC      
Schedule of Equity Method Investments [Line Items]      
Loan receivable   $ 1.5  
Annual interest rate (percent)   10.00%  
Loan receivable, carrying value $ 1.6    
Convertible debt securities and warrant, purchase price     $ 5.0
Recognized measurement gains   $ 0.4  
Loan receivable, fair value 1.6    
Convertible Debt Securities | BioCision, LLC      
Schedule of Equity Method Investments [Line Items]      
Investment maturity period   5 years  
Annual interest rate (percent)   9.00%  
Convertible debt securities, carrying value 5.8    
Other Assets | BioCision, LLC      
Schedule of Equity Method Investments [Line Items]      
Loan receivable, carrying value   $ 1.5  
Other Nonoperating Income (Expense) | Convertible Debt Securities      
Schedule of Equity Method Investments [Line Items]      
Loss on settlement of financial instruments 0.2    
Fair Value, Measurements, Recurring | Significant Unobservable Inputs (Level 3) | Convertible Debt Securities | BioCision, LLC      
Schedule of Equity Method Investments [Line Items]      
Convertible debt securities, fair value 5.6    
Fair Value, Measurements, Recurring | Warrants | Significant Unobservable Inputs (Level 3) | BioCision, LLC | Maximum      
Schedule of Equity Method Investments [Line Items]      
Stock warrant $ 0.1